8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body

Note: This study found no significant biological effects under its experimental conditions. We include all studies for scientific completeness.

DNA & Genetic Damage

Absence of a synergistic effect between moderate-power radio-frequency electromagnetic radiation and adriamycin on cell-cycle progression and sister-chromatid exchange.

No Effects Found

Ciaravino V, Meltz ML, Erwin DN · 1991

View Original Abstract
Share:

Microwave radiation at 33.8 W/kg didn't amplify DNA damage from a toxic cancer drug, but this extreme exposure far exceeds everyday wireless device levels.

Plain English Summary

Summary written for general audiences

Researchers exposed Chinese hamster ovary cells to both microwave radiation (2.45 GHz) and adriamycin, a cancer drug that damages DNA, to see if the radiation would amplify the drug's harmful effects. After two hours of simultaneous exposure at 33.8 W/kg (a relatively high power level), they found no synergistic effect - the radiation didn't make the drug more damaging to cells or increase DNA damage. This suggests that microwave radiation at this level doesn't interact with certain toxic chemicals to create additional cellular harm.

Exposure Information

A logarithmic frequency spectrum from 10 Hz to 100 GHz showing where this study's 2.45 GHz exposure sits relative to common EMF sources.Where This Frequency Sits on the EMF SpectrumELFVLFLF / MFHF / VHFUHFSHFmm10 Hz100 GHzThis study: 2.45 GHzPower lines50/60 Hz5G mm28 GHzLogarithmic scale

The study examined exposure from: 2,450 MHz Duration: 2 hours

Study Details

In our laboratories we are conducting investigations of potential interactions between radio-frequency electromagnetic radiation (RFR) and chemicals that are toxic by different mechanisms to mammalian cells

The RFR is being tested at frequencies in the microwave range and at different power levels. We repo...

Verified statistically, the data indicate that the RFR did not affect changes in cell progression ca...

Cite This Study
Ciaravino V, Meltz ML, Erwin DN (1991). Absence of a synergistic effect between moderate-power radio-frequency electromagnetic radiation and adriamycin on cell-cycle progression and sister-chromatid exchange. Bioelectromagnetics 12(5):289-298, 1991.
Show BibTeX
@article{v_1991_absence_of_a_synergistic_2981,
  author = {Ciaravino V and Meltz ML and Erwin DN},
  title = {Absence of a synergistic effect between moderate-power radio-frequency electromagnetic radiation and adriamycin on cell-cycle progression and sister-chromatid exchange.},
  year = {1991},
  
  url = {https://pubmed.ncbi.nlm.nih.gov/1759979/},
}
PubMed: 1759979

Cited By (56 papers)

View all 56 citing papers on Semantic Scholar

Quick Questions About This Study

A 1991 study found that 2.45 GHz microwave radiation did not amplify the DNA-damaging effects of adriamycin, a cancer chemotherapy drug. The research showed no synergistic effect when cells were exposed to both the radiation and drug simultaneously for two hours.
Research using Chinese hamster ovary cells exposed to 2.45 GHz microwave radiation at high power levels found no additional DNA damage beyond what occurred from a known DNA-damaging drug alone. The radiation did not increase genetic damage markers in this controlled study.
A laboratory study exposing cells to 2.45 GHz radiation (the same frequency used in microwave ovens) found no evidence that this radiation enhanced DNA damage when combined with a potent cancer drug known to harm genetic material.
Research suggests that 2.45 GHz microwave radiation does not amplify the cellular damage caused by certain toxic substances. A study combining this radiation with adriamycin, a DNA-damaging cancer drug, found no synergistic harmful effects on cells.
Laboratory testing of 2,450 MHz radiation on cells showed no increased DNA damage or interference with cell division cycles, even when combined with a chemotherapy drug specifically known to damage genetic material and cell membranes.